Six-month, phase I/II trial of sNN 0029 for amyotrophic lateral sclerosis.

Trial Profile

Six-month, phase I/II trial of sNN 0029 for amyotrophic lateral sclerosis.

Planning
Phase of Trial: Phase I/II

Latest Information Update: 16 Sep 2013

At a glance

  • Drugs SNN 0029 (Primary)
  • Indications Amyotrophic lateral sclerosis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 16 Sep 2013 Planned initiation date changed to 1 Dec 2013.
    • 06 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top